Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
Go back to Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 113.75 +6.22 (5.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.53 | 52 Week High | $118.49 | |||
| Open | $109.47 | 52 Week Low | $55.00 | |||
| Day High | $115.56 | P/E | N/A | |||
| Day Low | $109.48 | EPS | $-0.56 | |||
| Volume | 3,795,002 | |||||
